Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Acs Dobfar Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACS DOBFAR, and what generic and branded alternatives to ACS DOBFAR drugs are available?

ACS DOBFAR has twenty-three approved drugs.

Summary for Acs Dobfar
US Patents:0
Patent Litigation for Acs Dobfar: See patent lawsuits for Acs Dobfar

Drugs and US Patents for Acs Dobfar

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-002 Dec 21, 2011 AP RX No No   Start Trial   Start Trial
Acs Dobfar Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090889-001 Apr 3, 2013 AP RX No No   Start Trial   Start Trial
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Acs Dobfar KEFUROX cefuroxime sodium INJECTABLE;INJECTION 062591-002 Jan 10, 1986 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.